These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 21142776)
1. High levels of women's satisfaction and compliance with transdermal contraception: results from a European multinational, 6-month study. Jakimiuk AJ; Crosignani PG; Chernev T; Prilepskaya V; Bergmans P; Von Poncet M; Marelli S; Lee EJ Gynecol Endocrinol; 2011 Oct; 27(10):849-56. PubMed ID: 21142776 [TBL] [Abstract][Full Text] [Related]
2. Satisfaction and compliance in hormonal contraception: the result of a multicentre clinical study on women's experience with the ethinylestradiol/norelgestromin contraceptive patch in Italy. Crosignani PG; Nappi C; Ronsini S; Bruni V; Marelli S; Sonnino D; BMC Womens Health; 2009 Jun; 9():18. PubMed ID: 19566925 [TBL] [Abstract][Full Text] [Related]
3. Preference for and satisfaction of Canadian women with the transdermal contraceptive patch versus previous contraceptive method: an open-label, multicentre study. Weisberg F; Bouchard C; Moreau M; Audet MC; Mawdsley S; Dattani D; Dinniwell J; Horbay GL; J Obstet Gynaecol Can; 2005 Apr; 27(4):350-9. PubMed ID: 15937609 [TBL] [Abstract][Full Text] [Related]
4. Transdermal ethinylestradiol/norelgestromin: a review of its use in hormonal contraception. Goa KL; Warner GT; Easthope SE Treat Endocrinol; 2003; 2(3):191-206. PubMed ID: 15966567 [TBL] [Abstract][Full Text] [Related]
5. Adolescents' experiences using the contraceptive patch versus pills. Sucato GS; Land SR; Murray PJ; Cecchini R; Gold MA J Pediatr Adolesc Gynecol; 2011 Aug; 24(4):197-203. PubMed ID: 21454110 [TBL] [Abstract][Full Text] [Related]
7. A clinical study of transdermal contraceptive patch in Thai adolescence women. Piyasirisilp R; Taneepanichskul S J Med Assoc Thai; 2008 Feb; 91(2):137-41. PubMed ID: 18389975 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the contraceptive efficacy, compliance, and satisfaction with the transdermal contraceptive patch system Evra: a comparison between adolescent and adult users. Bodner K; Bodner-Adler B; Grünberger W Arch Gynecol Obstet; 2011 Mar; 283(3):525-30. PubMed ID: 20111970 [TBL] [Abstract][Full Text] [Related]
9. New Product Review (September 2003). Norelgestromin/ethinyl oestradiol transdermal contraceptive system (Evra). Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit J Fam Plann Reprod Health Care; 2004 Jan; 30(1):43-5. PubMed ID: 15006313 [TBL] [Abstract][Full Text] [Related]
11. A comparison of bleeding patterns and cycle control using two transdermal contraceptive systems: a multicenter, open-label, randomized study. Gruber D; Skřivánek A; Serrani M; Lanius V; Merz M Contraception; 2015 Feb; 91(2):105-12. PubMed ID: 25453582 [TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of a new triphasic oral contraceptive: norgestimate and ethinyl estradiol. Gauthier A; Upmalis D; Dain MP Acta Obstet Gynecol Scand Suppl; 1992; 156():27-32. PubMed ID: 1324554 [TBL] [Abstract][Full Text] [Related]
17. Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol. Jick S; Kaye JA; Li L; Jick H Contraception; 2007 Jul; 76(1):4-7. PubMed ID: 17586129 [TBL] [Abstract][Full Text] [Related]
19. [Safety evaluation of a transdermal contraceptive system with an oral contraceptive]. Radowicki S; Skórzewska K; Szlendak K Ginekol Pol; 2005 Nov; 76(11):884-9. PubMed ID: 16566363 [TBL] [Abstract][Full Text] [Related]